Subcutaneous Drug Delivery Devices Market to Reach US$ 17,290.47 Mn at a CAGR of 7.4% in 2027 | The Insight Partners

Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology (Syringes, Pens, Patches, Others); Syringe Type (Prefilled Injectable, Filled Injectable); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Publication Month: Sep 2019 | Report Code: TIPRE00006411 | No. of Pages: 157 | Category: Medical Device | Status: Published

The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

 

The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new products leading to the subsequent introduction of novel solutions and devices in the market are expected to account for the growth of the market. However, risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.

 

Exhibit: Lucrative Regional Subcutaneous Drug Delivery Devices Markets




Market Insights

Technological Advancements and Increasing Product Launches

The advancement in the field of the healthcare industry is driving to the players for more research and developments for the subcutaneous drug delivery devices for the administration purpose required during various medical conditions. Various manufacturers are coming up with innovative products to sustain in the highly fragmented global market. Moreover, the easy regulatory approvals in the Asian countries has led to mid-sized companies enter the market and compete with the local and established players. For instance, in June 2016, Haselmeier announces the German launch of the BerliPen areo 3 through Berlin-Chemie. Key features of this third-generation BerliPen are an optimized dose indicator, innovative low-friction mechanism for smooth injection release in addition to an enhanced feeling of safety by means of audible and tactile dose settings. Moreover, in April 2016, Emperra GmbH launched a new Bluetooth insulin pen model. The new ESYSTA BT pen is equipped with a Bluetooth interface and transfers the injected insulin doses directly to the patient’s digital blood glucose diary. Thus, owing to rising number of novel product launches and approvals, the subcutaneous drug delivery devices market is expected to witness rapid growth.

 

Increasing Incidence of Chronic Diseases

Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to increasing prevalence of chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in the 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. Also, cancer is one of the leading cause of death in the North America region. Furthermore, the American Cancer Society (ACS) estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed. Targeted drug delivery system (TDDS) is a system, which delivers the drug in a controlled manner at a preselected biosite. Nanotechnology based delivery systems are making a significant impact on cancer treatment and the polymers play key role in the development of nanoparticulate carriers for cancer therapy. Some important technological advantages of nanotherapeutic drug delivery systems (NDDS) include prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of drug and many more. Thus, the increasing prevalence and incidences of chronic and lifestyle diseases poses several opportunities for the subcutaneous drug delivery systems market to grow during the forecast period.

 

Syringe Type Insights

The global subcutaneous drug delivery devices market, based on the syringe type was segmented into fillable injectable and prefilled injectable. In 2018, the fillable injectable held a largest market share of the subcutaneous drug delivery devices market, by syringe type. However, the prefilled injectable segment is expected to witness the highest CAGR over the coming years. The use of prefilled injectable devices such as syringes have expanded and overcame the traditional drug delivery approaches. Moreover, these syringes have been utilized across multiple therapeutic sectors including blood stimulants, vaccines, therapeutic protein, hormones, drugs, supplements, nutraceuticals and others.

 

Exhibit: Subcutaneous Drug Delivery Devices Market, by Syringe Type


 

Strategic Insights

Some of the organic and inorganic growth activities are undertaken by the company, which have promoted the market growth. The companies have utilized strategies such as product launches, product approvals the growth of companies which is further expected to enhance the growth of the market during the coming years. For instance, in June 2018, Insulet received FDA 510(k) clearance for the Omnipod DASHTM Insulin Management System (Omnipod DASH). This clearance set up the foundation for a stable pace of innovation that enables Insulet to allow users to enjoy simplicity, healthier lives, and freedom swith their differentiated technology.

 

 

GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET SEGMENTATION

Global Subcutaneous Drug Delivery Devices Market – By Technology

  • Syringes
  • Pens
  • Patches
  • Others

Global Subcutaneous Drug Delivery Devices Market – By Syringe Type

  • Prefilled Injectable
  • Filled Injectable

Global Subcutaneous Drug Delivery Devices Market – By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Subcutaneous Drug Delivery Devices Market – By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • South America (SAM)
  • Brazil
  • Argentina

 

Company Profiles

  • Insulet Corporation
  • BD
  • Enable Injections
  • Consort Medical Plc
  • West Pharmaceutical Services, Inc.
  • Elcam Medical
  • Amgen
  • Ypsomed AG
  • SCPharmaceuticals, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1       Global Subcutaneous Drug Delivery Devices Market – By Technology

1.3.2       Global Subcutaneous Drug Delivery Devices Market – By Syringe Type

1.3.3       Global Subcutaneous Drug Delivery Devices Market – By Distribution Channel

1.3.4       Global Subcutaneous Drug Delivery Devices Market – By Geography

2.             Global Subcutaneous Drug Delivery Devices Market –  Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Subcutaneous Drug Delivery Devices– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       North America PEST Analysis

4.2.2       Europe PEST Analysis

4.2.3       Asia Pacific – PEST Analysis

4.2.4       Middle East & Africa– PEST Analysis

4.2.5       South & Central America – PEST Analysis

4.3       Expert Opinions

5.             Global Subcutaneous Drug Delivery Devices Market –  Key Industry Dynamics

5.1.1       Increasing Incidence of Chronic Diseases

5.1.2       Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies

5.1.3       Technological Advancements and Increasing Product Launches

5.2       Key Market Restraints

5.2.1       Risks Associated with Injections:

5.3       Key Market Opportunities

5.3.1       Development of Products As Per Patient Compliance

5.4       Future Trends

5.4.1       Growing Product Innovations through Collaborative Research:

5.4.2       Rapid Adoption of Pre-Filled Saline Syringes

5.5       Impact Analysis

6.             Subcutaneous Drug Delivery Devices Market – Global Analysis

6.1       Global Subcutaneous Drug Delivery Devices Market Revenue Forecasts And Analysis

6.2       Global Subcutaneous Drug Delivery Devices Market, By Geography - Forecasts And Analysis

6.3       Market Positioning of Key Players

7.             Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 – Technology

7.1       Overview

7.2       Global Subcutaneous Drug Delivery Devices Market Share by Technology 2018 & 2027 (%)

7.3       Syringes Market

7.3.1       Overview

7.3.2       Syringes Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3       Pens

7.3.3.1    Overview

7.3.3.2    Pens Market Revenue and Forecast to 2027 (US$ Mn)

7.3.4       Patches

7.3.4.1    Overview

7.3.4.2    Patches Market Revenue and Forecast to 2027 (US$ Mn)

7.3.5       Others

7.3.5.1    Overview

7.3.5.2    Others Market Revenue and Forecast to 2027 (US$ Mn)

8.             Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 – Syringe Type

8.1       Overview

8.2       Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)

8.3       Prefilled Injectable Market

8.3.1       Overview

8.3.2       Prefilled Injectable Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Fillable Injectable Market

8.4.1       Overview

8.4.2       Fillable Injectable Market Revenue and Forecast to 2027 (US$ Mn)

9.             Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 – Distribution Channel

9.1       Overview

9.2       Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)

9.3       Hospital Pharmacies Market

9.3.1       Overview

9.3.2       Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.4       Retail Pharmacies Market

9.4.1       Overview

9.4.2       Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Online Pharmacies Market

9.5.1       Overview

9.5.2       Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

10.          Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1    North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027

10.1.1    North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.2    North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)

10.3    North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

10.4    North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Distribution Channel (US$ Mn)

10.4.1    North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

10.4.2    US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.2.1  US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.2.2  US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.2.3  US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.4.2.4  US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

10.4.3    Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.3.1  Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.3.2  Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.3.3  Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.4.3.4  Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4.4    Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.4.1  Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.4.2  Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.4.3  Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.4.4.4  Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

10.5    Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027

10.5.1    Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.6    Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

10.7    Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.8    Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.8.1    Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

10.8.2    UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.2.1  UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.2.2  UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.8.2.3  UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.8.2.4  UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

10.8.3    Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.3.1  Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.3.2  Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.8.3.3  Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.8.3.4  Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.8.4    France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.4.1  France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.4.2  France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.8.4.3  France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.8.4.4  France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

10.8.5    Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.5.1  Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.5.2  Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.8.5.3  Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.8.5.4  Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

10.8.6    Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.6.1  Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.6.2  Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.8.6.3  Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

10.8.6.4  Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

11.          Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

11.1    Overview

11.2    Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.3    Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.4    Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

11.5    Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.6    Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

11.7    Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.7.1    Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.7.1.1  Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.7.1.2  Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

11.7.1.3  Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

11.8    China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.8.1    China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.8.1.1  China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.8.1.2  China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

11.8.1.3  China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

11.9    India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.9.1    India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.9.1.1  India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.9.1.2  India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

11.9.1.3  India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

11.10  Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.10.1 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.10.1.1.. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.10.1.2.. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

11.10.1.3.. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.11  South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.11.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

11.11.1.1... South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.11.1.2... South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

11.11.1.3... South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

12.          Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

12.1    Overview

12.2    Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027  (US$ Mn)

12.3    Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)

12.4    Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Syringe Type (US$ Mn)

12.5    Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Distribution Channel (US$ Mn)

12.6    Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027,  By Country (%)

12.7    South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

12.7.1    South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

12.7.1.1  South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.7.1.2  South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

12.7.1.3  South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

12.8    Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

12.8.1    Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

12.8.1.1  Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

12.8.1.2  Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

12.8.1.3  Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

12.9    UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

12.9.1    UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

12.9.1.1  UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

12.9.1.2  UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

12.9.1.3  UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

13.          South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

13.1    Overview

13.2    South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

13.3    South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

13.4    South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

13.5    South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

13.6    South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

13.7    Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

13.7.1.1  Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

13.7.1.2  Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

13.7.1.3  Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

13.7.1.4  Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

13.7.2    Argentina Subcutaneous Drug Delivery Devices Market

13.7.2.1  Argentina Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

13.7.2.2  Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

13.7.2.3  Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

13.7.2.4  Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

14.          Subcutaneous Drug Delivery Devices Market – Industry Landscape

14.1    Overview

14.2    Growth Strategies done by the companies in the Market, (%)

14.3    Organic Developments

14.3.1    Overview

14.4    Inorganic developments

14.4.1    Overview

15.          Subcutaneous Drug Delivery Devices Market –  Key Company Profiles

15.1    Insulet Corporation

15.1.1    Key Facts

15.1.2    Business Description

15.1.3    Financial Information

15.1.4    Product Portfolio

15.1.5    SWOT Analysis

15.1.6    Key Developments

15.2    BD

15.2.1    Key Facts

15.2.2    Business Description

15.2.3    Financial Overview

15.2.4    Product Portfolio

15.2.5    SWOT Analysis

15.2.6    Key Developments

15.3    Amgen Inc.

15.3.1    Key Facts

15.3.2    Business Description

15.3.3    Financial Overview

15.3.4    Product Portfolio

15.3.5    SWOT Analysis

15.3.6    Key Developments

15.4    ELCAM Medical

15.4.1    Key Facts

15.4.2    Business Description

15.4.3    Financial Overview

15.4.4    Product Portfolio

15.4.5    SWOT Analysis

15.4.6    Key Developments.

15.5    Ypsomed AG

15.5.1    Key Facts

15.5.2    Business Description

15.5.3    Financial Information

15.5.4    Product Portfolio

15.5.5    SWOT Analysis

15.5.6    Key Developments

15.6    West Pharmaceutical Services, Inc

15.6.1    Key Facts

15.6.2    Business Description

15.6.3    Financial Information

15.6.4    Product Portfolio

15.6.5    SWOT Analysis

15.6.6    Key Developments

15.7    Scpharmaceuticals, Inc.

15.7.1    Key Facts

15.7.2    Business Description

15.7.3    Financial Overview

15.7.4    Product Portfolio

15.7.5    SWOT Analysis

15.7.6    Key Developments.

15.8    Wilhelm Haselmeier GmbH and Co. KG

15.8.1    Key Facts

15.8.2    Business Description

15.8.3    Financial Overview

15.8.4    Product Portfolio

15.8.5    SWOT Analysis

15.8.6    Key Developments

15.9    Consort Medical PLC

15.9.1    Key Facts

15.9.2    Business Description

15.9.3    Financial Overview

15.9.4    Product Portfolio

15.9.5    SWOT Analysis

15.9.6    Key Developments

15.10  Enable Injections, Inc.

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Financial Overview

15.10.4 Product Portfolio

15.10.5 SWOT Analysis

15.10.6 Key Developments

16.          Appendix

16.1    About The Insight Partners

16.2    Glossary Of Terms


LIST OF TABLES

Table 1.            R&D Investments by Major Pharmaceutical Companies

Table 2.            North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 3.            North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 4.            North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 5.            US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 6.            US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 7.            US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

Table 8.            Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 9.            Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

Table 10.         Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 11.         Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 12.         Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 13.         Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 14.         Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 15.         Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 16.         Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 17.         UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 18.         UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 19.         UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

Table 20.         Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 21.         Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

Table 22.         Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 23.         France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 24.         France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 25.         France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 26.         Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 27.         Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 28.         Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 29.         Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 30.         Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 31.         Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 32.         Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 33.         Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

Table 34.         Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 35.         Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 36.         Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 37.         Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 38.         China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 39.         China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 40.         China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 41.         India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 42.         India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 43.         India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 44.         Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 45.         Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

Table 46.         Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 47.         South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 48.         South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 49.         South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 50.         Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)

Table 51.         Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 52.         Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Distribution Channel (US$ Mn)

Table 53.         South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 54.         South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 55.         South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 56.         Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 57.         Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 58.         Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 59.         UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 60.         UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 61.         UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 62.         South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)

Table 63.         South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Syringe Type (US$ Mn)

Table 64.         South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027,  By Distribution Channel (US$ Mn)

Table 65.         Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 66.         Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)

Table 67.         Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 68.         Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 69.         Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type  (US$ Mn)

Table 70.         Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 71.         Organic Developments Done By Companies

Table 72.         Inorganic developments done by Companies

Table 73.         Glossary Of Terms, Subcutaneous Drug Delivery Devices Market

 

LIST OF FIGURES

Figure 1.          Subcutaneous Drug Delivery Devices Market Segmentation

Figure 2.          Subcutaneous Drug Delivery Devices Segmentation, By Region

Figure 3.          Global Subcutaneous Drug Delivery Devices Market Overview

Figure 4.          Fillable Injectable Segment Held Largest Share Of The Syringe Type Segment In Subcutaneous Drug Delivery Devices Market

Figure 5.          North America Region Is Expected To Show Remarkable Growth During The Forecast Period

Figure 6.          Global Subcutaneous Drug Delivery Devices Market, By Geography (US$ Mn)

Figure 7.          Global Subcutaneous Drug Delivery Devices Market- Leading Country Markets (US$ Mn)

Figure 8.          Global Subcutaneous Drug Delivery Devices Market, Industry Landscape

Figure 9.          North America : PEST Analysis

Figure 10.       Europe: PEST Analysis

Figure 11.       Asia Pacific PEST Analysis

Figure 12.       Middle East & Africa PEST Analysis

Figure 13.       South & Central America PEST Analysis

Figure 14.       Global Subcutaneous Drug Delivery Devices Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 15.       Global Subcutaneous Drug Delivery Devices Market – By Geography Forecasts And Analysis – 2018- 2027

Figure 16.       Global Subcutaneous Drug Delivery Devices Market – Market Positioning

Figure 17.       Global Subcutaneous Drug Delivery Devices Market Share By Technology 2018 & 2027 (%)

Figure 18.       Syringes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Patches Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)

Figure 23.       Prefilled Injectable Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Fillable Injectable Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)

Figure 26.       Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       North America Subcutaneous Drug Delivery Devices Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 30.       North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

Figure 32.       US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.       Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       Europe Subcutaneous Drug Delivery Devices Market Revenue Overview, by Country, 2018 (US$ MN)

Figure 36.       Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

Figure 38.       UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.       Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Asia Pacific Subcutaneous Drug Delivery Devices Market Overview, by Country (2017)

Figure 44.       Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)

Figure 46.       Japan Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.       China Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.       India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50.       South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       Middle East & Africa Subcutaneous Drug Delivery Devices Market Overview, by Country (2018)

Figure 52.       Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53.       Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027,  By Country (%)

Figure 54.       South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55.       Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 56.       UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.       South and Central America Subcutaneous Drug Delivery Devices Market Overview, by Country (2018)

Figure 58.       South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 59.       South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027,  By Country (%)

Figure 60.       Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 61.       Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 62.       Growth Strategies done by the companies in the Market, (%)

 

The List of Companies

  1. Insulet Corporation
  2. BD
  3. Enable Injections
  4. Consort Medical Plc
  5. West Pharmaceutical Services, Inc.
  6. Elcam Medical
  7. Amgen
  8. Ypsomed AG
  9. SCPharmaceuticals, Inc.
  10. Wilhelm Haselmeier GmbH & Co. KG

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the subcutaneous drug delivery devices market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global subcutaneous drug delivery devices market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.